RT Journal Article
SR Electronic
T1 Screening for SARS-CoV-2 infections with colorimetric RT-LAMP and LAMP sequencing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20092288
DO 10.1101/2020.05.05.20092288
A1 Thi, Viet Loan Dao
A1 Herbst, Konrad
A1 Boerner, Kathleen
A1 Meurer, Matthias
A1 Kremer, Lukas PM
A1 Kirrmaier, Daniel
A1 Freistaedter, Andrew
A1 Papagiannidis, Dimitrios
A1 Galmozzi, Carla
A1 Klein, Steffen
A1 Chlanda, Petr
A1 Khalid, Dina
A1 Miranda, Isabel Barreto
A1 Schnitzler, Paul
A1 Kräusslich, Hans-Georg
A1 Knop, Michael
A1 Anders, Simon
YR 2020
UL http://medrxiv.org/content/early/2020/05/09/2020.05.05.20092288.abstract
AB The COVID-19 pandemic caused by the novel SARS-CoV-2 virus poses a significant public-health problem. In order to control the pandemic, rapid tests for detecting existing infections and assessing virus spread are critical.Approaches to detect viral RNA based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) hold outstanding promise towards greatly simplified and broadly applicable testing methods. RT-LAMP assays appear more robust than qPCR-based methods and only require incubation at a constant temperature, thus eliminating the need for sophisticated instrumentation.Here, we tested a two-color RT-LAMP protocol using clinical SARS-CoV-2 samples and also established a protocol that does not require prior RNA isolation (“swab-to-RT-LAMP”). Our study is based on several hundred clinical patient samples with a wide range of viral loads, thus allowing, for the first time, to accurately determine the sensitivity and specificity of the RT-LAMP assay for the detection of SARS-CoV-2 in patients. We found that RT-LAMP can reliably detect SARS-CoV-2 samples with a qPCR threshold cycle number (CT value) of up to 30 in the standard RT-qPCR assay. We used both, either purified RNA or direct pharyngeal swab specimens and showed that RT-LAMP assays have, despite a decreased sensitivity compared to RT-qPCR, excellent specificity. We also developed a multiplexed LAMP-sequencing protocol as a diagnostic and validation procedure to detect and record the outcome of RT-LAMP assays. LAMP-sequencing is fully scalable and can assess the results of thousands of LAMP reactions in parallel. Finally, we propose applications of RT-LAMP based assays for SARS-CoV-2 detection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementVLDT and AF were supported by the Chica and Heinz Schaller foundation. DK was funded through internal funds from the DKFZ.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata is available from https://github.com/anders-biostat/LAMP-Paper-Figures/ https://github.com/anders-biostat/LAMP-Paper-Figures/